EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Stage 1 Registered Report: Rationale, design and study protocol for a prospective, exploratory study Predicting Response to image-Guided Cryoneurolysis of the Greater Occipital Nerve (CryoGON) in Chronic Migraine Using a Conventional Greater Occipital Nerve Block.

Tore Wergeland iD, Melanie Rae Simpson iD, Irina Aschehoug, Lise Rystad Øie, Kristina Devik, Martha Brakestad Larsen, Sverre Myren, Erling Andreas Tronvik, Daniel Fossum Bratbak

F1000Research · 2026

DOI: 10.12688/f1000research.171975.2 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift F1000Research, 2026. Verfasst von Tore Wergeland und 8 weiteren Autor:innen. Beteiligte Einrichtung: Norwegian Centre for Headache Research (NorHEAD), Norwegian University of Science and Technology (NTNU), Trondheim, Norway. Hauptthemen laut MEDLINE: Migraine Disorders, Nerve Block, Cryosurgery. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The DAM Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic migraine is frequently refractory to available preventive therapies. Image-guided cryoneurolysis of the greater occipital nerve (CryoGON) may provide longer-lasting relief than conventional greater occipital nerve (GON) blocks. This Stage 1 Registered Report describes a prospective, exploratory study evaluating whether response to a conventional GON block predicts subsequent response to CryoGON, and assesses open-label safety, tolerability, feasibility and efficacy of CryoGON.

Methods

The study is planned as a single-site, investigator-initiated, open-label clinical investigation. Adults with chronic migraine will complete a ≥28-day electronic baseline diary before receiving bilateral conventional GON blocks, followed by a ≥28-day observation. Eligible participants then undergo navigation-guided CryoGON with 12-week follow-up. The primary endpoint is the association between change in moderate-to-severe headache days after GON block (weeks 1–4) and after CryoGON (weeks 9–12). Key secondary endpoints estimate the diagnostic performance of GON-block response applying a ≥30% reduction threshold for treatment effect to identify CryoGON responders, including sensitivity, specificity and predictive values. Additional endpoints include change in migraine days, patient-reported global impression of change, Migraine-Specific Quality of Life Questionnaire v2.1, procedure tolerability, technical success, and safety (treatment-emergent adverse events and adverse device effects). Women of childbearing potential, including pregnant and breastfeeding participants, are eligible for participation.

Discussion

This study will provide the first systematic evaluation of whether a simple, widely available GON block can guide patient selection for CryoGON and will generate foundational open-label data on its clinical performance and safety. Findings will inform the design and justification of a subsequent sham-controlled trial. Trial registration and approvals The study will preregister at ClinicalTrials.gov. and obtain all necessary ethical approvals before study initiation. Sponsor: St. Olav’s University Hospital, Trondheim, Norway. Funding: Stiftelsen Dam (grant SDAM_FOR701626).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersNerve BlockCryosurgeryHumansProspective StudiesFemaleChronic DiseaseAdultMaleTreatment OutcomeMiddle Aged

Stichwörter der Autor:innen

CryoneurolysisGONchronic migraine

Autor:innen und Institutionen

  • Norwegian Centre for Headache Research (NorHEAD), Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Department of neurology and neurophysiology, St Olav's University Hospital, Trondheim, Norway.
  • Department of Neuromedicine and Movement Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Neurology, Nord Trøndelag Trust, Namsos, Norway.
  • Department of Neurology, Molde Hospital, Molde, Norway.

ORCID-Profile: Tore Wergeland, Melanie Rae Simpson

Förderung

  • The DAM Foundation

Zitieren

APA

Wergeland, T., Simpson, M. R., Aschehoug, I., Øie, L. R., Devik, K., Larsen, M. B., Myren, S., Tronvik, E. A., & Bratbak, D. F. (2026). Stage 1 Registered Report: Rationale, design and study protocol for a prospective, exploratory study Predicting Response to image-Guided Cryoneurolysis of the Greater Occipital Nerve (CryoGON) in Chronic Migraine Using a Conventional Greater Occipital Nerve Block. F1000Research. https://doi.org/10.12688/f1000research.171975.2

Vancouver

Wergeland T, Simpson MR, Aschehoug I, Øie LR, Devik K, Larsen MB, et al. Stage 1 Registered Report: Rationale, design and study protocol for a prospective, exploratory study Predicting Response to image-Guided Cryoneurolysis of the Greater Occipital Nerve (CryoGON) in Chronic Migraine Using a Conventional Greater Occipital Nerve Block. F1000Research. 2026. doi:10.12688/f1000research.171975.2

BibTeX
@article{Wergeland2026,
  author = {Wergeland, Tore and Simpson, Melanie Rae and Aschehoug, Irina and Øie, Lise Rystad and Devik, Kristina and Larsen, Martha Brakestad and Myren, Sverre and Tronvik, Erling Andreas and Bratbak, Daniel Fossum},
  title = {Stage 1 Registered Report: Rationale, design and study protocol for a prospective, exploratory study Predicting Response to image-Guided Cryoneurolysis of the Greater Occipital Nerve (CryoGON) in Chronic Migraine Using a Conventional Greater Occipital Nerve Block},
  journal = {F1000Research},
  year = {2026},
  doi = {10.12688/f1000research.171975.2}
}
Kostenlos starten →